Allspring Global Investments Holdings, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 357 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.

Quarter-by-quarter ownership
Allspring Global Investments Holdings, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$33,893,898
+190.7%
887,274
+174.5%
0.06%
+215.8%
Q2 2023$11,660,900
+25.8%
323,285
+33.2%
0.02%
+26.7%
Q1 2023$9,268,827
-59.1%
242,703
-39.1%
0.02%
-61.5%
Q4 2022$22,658,490
-22.9%
398,216
-46.5%
0.04%
-25.0%
Q3 2022$29,405,000
+6.8%
743,687
+18.8%
0.05%
+13.0%
Q2 2022$27,545,000
-1.2%
626,042
-10.4%
0.05%
+31.4%
Q1 2022$27,872,000
-22.1%
698,904
-21.5%
0.04%
-12.5%
Q4 2021$35,784,000889,9370.04%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
TRAN CAPITAL MANAGEMENT, L.P. 1,084,118$61,686,2857.80%
SNYDER CAPITAL MANAGEMENT L P 3,983,814$226,679,0175.12%
First Light Asset Management, LLC 923,119$52,525,4714.88%
Redwood Investments, LLC 441,809$25,138,9323.37%
BERNZOTT CAPITAL ADVISORS 444,728$25,305,0233.27%
DOHENY ASSET MANAGEMENT /CA 46,050$2,6203.04%
Crawford Lake Capital Management, LLC 42,171$2,399,5302.75%
2Xideas AG 416,586$23,703,7432.51%
Granite Investment Partners, LLC 902,882$51,373,9862.14%
HighMark Wealth Management LLC 41,790$2,377,8511.79%
View complete list of HALOZYME THERAPEUTICS INC shareholders